Intuitive Surgical Reports Strong Q4 2024 Performance

Intuitive Surgical showcased robust Q4 2024 results. With significant revenue growth and a strategic focus on new product launches, the company's strong performance may positively impact investor sentiment.

Date: 24-01-2025

AI Rating: 7

Performance Highlights: Intuitive Surgical reported a strong financial performance for the full year 2024, with a revenue of $8.4 billion, reflecting a 17% growth year-over-year. The latest quarter achieved revenue of $2.41 billion, a 25% increase compared to the previous year. Strong procedure growth and system placements contributed significantly to these results.

Earnings Per Share (EPS): The pro forma EPS increased by 28%, indicating strengthened profitability and positive long-term growth prospects for the company. The latest reported EPS was $2.21 for Q4 2024, compared to $1.60 for the same quarter last year.

Revenue Growth: A notable revenue increase was highlighted, with Q4 showing a 25% growth and overall annual revenue reaching $8.4 billion. The growth is attributed to rising demand for the da Vinci robotic systems and increased procedure volumes, with over 2.68 million procedures performed globally in 2024.

Profit Margins: The pro forma gross margin improved to 69.5% in Q4 2024 from 68% in Q4 2023, indicating enhanced operational efficiency and cost management strategies. Furthermore, the pro forma operating margin for Q4 was recorded at 38%, demonstrating financial stability and operational growth.

Future Outlook: For 2025, Intuitive Surgical anticipates continued revenue growth and an increase in procedure volumes, indicating strong confidence in market expansion. Despite projections for a slightly lower pro forma gross profit margin for 2025 (expected between 67% and 68%), the long-term outlook remains positive due to ongoing innovations and product enhancements.

Stocks: ISRG